Table 3. Factors associated with propofol injection from multiple logistic regression (N = 252).
| Adjusted OR | 95% CI | P value | ||
|---|---|---|---|---|
| Sex | ||||
| Female | 1 | - | - | |
| Male | 1.74 | 0.47 | 6.51 | 0.41 |
| Age group | ||||
| 20–34 | 1 | - | - | |
| 35–44 | 1.42 | 0.46 | 4.35 | 0.54 |
| ≥45 | 0.38 | 0.09 | 1.46 | 0.16 |
| Education | ||||
| ≤9 years | 1 | - | - | |
| >9 years | 1.23 | 0.52 | 2.92 | 0.63 |
| HIV reported year | ||||
| 2014 | 1 | - | - | |
| 2015 | 4.00 | 1.08 | 14.86 | 0.04 |
| 2016 | 2.11 | 0.52 | 8.63 | 0.30 |
| 2017 | 0.38 | 0.04 | 3.89 | 0.42 |
| Ever MMT* | ||||
| no | 1 | - | - | |
| yes | 2.43 | 0.98 | 5.98 | 0.05 |
| Ever incarcerated | ||||
| no | 1 | - | - | |
| yes | 0.86 | 0.36 | 2.05 | 0.73 |
* MMT: methadone maintenance therapy